Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexFemale

Age18+

SponsorConnecticut Children's Medical Center

About this trial

The rationale for fetal therapy in severe congenital diaphragmatic hernia (CDH) is to restore adequate lung growth for neonatal survival.

Pregnant women age 18 years and older, who are able to consent

Singleton pregnancy

Normal Karyotype

Fetal Diagnosis of Isolated Left CDH with liver up

Pregnant women <18 years of age.

Maternal contraindication to fetoscopic surgery or severe maternal medical condition in pregnancy

Technical limitations precluding fetoscopic surgery

Rubber latex allergy

15 Participants

are divided into 1 treatment group

Connecticut Children's Medical Center

Lead sponsor